|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Welcome Welcome to EUSA Pharma EUSA Pharma is a specialty pharmaceutical company with a strong and growing portfolio of specialized hospital medicines focused on oncology, pain control and critical care, which it markets predominantly in Europe and the US (as the company’s name suggests). EUSA Pharma has grown rapidly since its formation in 2006, and now incorporates Talisker Pharmaceuticals, which it acquired in July 2006, OPi, purchased in March 2007, the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc, acquired in August 2007, and Cytogen, which EUSA purchased in May 2008.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See us at:
EFORT 2-5 JuneMadrid, Spain - Booth 62
EFORT 2-5 JuneMadrid, Spain - Booth 62
ASCO 4-8 JuneChicago, USA - Booth 19134
EHA Congress 10-15 JuneBarcelona, Spain - Booth 30
MASCC 24-26 JuneVancouver, Canada - Booth tbc
ESMO 8-12 OctoberMilan, Italy - Booth 87
Last Updated: 6th July 2010
| Back to home page | Legal | Privacy | Compliance |
